Teva is maintaining silence on media reports published this week suggesting that the Israeli company has abandoned efforts to reach a settlement over price-fixing allegations with the US Department of Justice.
A New York Times report indicating that Teva has walked away from discussions with the DoJ – citing unidentified “people on both sides of the negotiations” – saw its
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?